Beijing Strong Biotechnologies, Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 711.06 million compared to CNY 807.18 million a year ago. Revenue was CNY 712.01 million compared to CNY 807.81 million a year ago.

Net income was CNY 162.85 million compared to CNY 221.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.38 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.38 a year ago.